Top compounds associated with response to EGLN3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.24 6e-09
mRNA TW 37 GDSC1000 pan-cancer AAC -0.17 6e-07
mRNA lapatinib CCLE pan-cancer AAC 0.19 4e-05
mRNA Erlotinib CCLE pan-cancer AAC 0.19 8e-05
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA ML083 CTRPv2 pan-cancer AAC 0.14 0.0008
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC 0.14 0.0009
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0009
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC 0.19 0.001
mRNA etomoxir CTRPv2 pan-cancer AAC 0.13 0.001
Download CSV